Management of a complete mole and coexisting fetus in post-dobbs world.

Abortion Cell free DNA Coexisting twin Dobbs Molar Pregnancy

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 11 01 2024
revised: 21 03 2024
accepted: 22 03 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: epublish

Résumé

Twin pregnancies consisting of a complete hydatidiform mole and a coexistent fetus (CMCF) are rare and associated with a high rate of maternal-fetal morbidity and mortality. Management of these pregnancies remains controversial and increasingly challenging following the This case looks at the diagnosis, management, and maternal-fetal outcomes of a viable fetus coexisting molar pregnancy at a large academic center in an abortion-restricted state. CMCF pregnancies are associated with a high risk of morbidity and mortality and are increasingly difficult to manage following the Dobbs decision. Testing platforms, which identify genetic abnormalities in the first trimester, are increasingly important as access to abortion care in the United States is restricted.

Sections du résumé

BACKGROUND BACKGROUND
Twin pregnancies consisting of a complete hydatidiform mole and a coexistent fetus (CMCF) are rare and associated with a high rate of maternal-fetal morbidity and mortality. Management of these pregnancies remains controversial and increasingly challenging following the
CASE METHODS
This case looks at the diagnosis, management, and maternal-fetal outcomes of a viable fetus coexisting molar pregnancy at a large academic center in an abortion-restricted state.
CONCLUSION CONCLUSIONS
CMCF pregnancies are associated with a high risk of morbidity and mortality and are increasingly difficult to manage following the Dobbs decision. Testing platforms, which identify genetic abnormalities in the first trimester, are increasingly important as access to abortion care in the United States is restricted.

Identifiants

pubmed: 38571565
doi: 10.1016/j.gore.2024.101375
pii: S2352-5789(24)00054-7
pmc: PMC10987889
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101375

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jordan Barton Garcia (JB)

University of Alabama at Birmingham Department of Obstetrics and Gynecology, United States.

Angela R Seasely (AR)

University of Alabama at Birmingham Division of Maternal Fetal Medicine, United States.

Damien Roland (D)

University of Alabama at Birmingham Department of Pathology, United States.

Hua Guo (H)

University of Alabama at Birmingham Department of Pathology, United States.

Margaret Boozer (M)

University of Alabama at Birmingham Division of Women's Reproductive Healthcare, United States.

Gabriella Cozzi (G)

University of Alabama at Birmingham Division of Maternal Fetal Medicine, United States.

Michael D Toboni (MD)

University of Alabama at Birmingham Division of Gynecology Oncology, United States.

Classifications MeSH